# Borderline Personality Disorder

Borderline personality disorder requires structured longitudinal diagnosis, active suicide-risk assessment, and referral to a coherent disorder-specific psychotherapy. Avoid reflexive crisis pharmacotherapy and unstructured prolonged hospitalization; target medications to independently diagnosed comorbid disorders and build a crisis plan around measurable risk and treatment continuity.

**Clinical question:** How should physicians diagnose, triage, and longitudinally treat borderline personality disorder while managing self-harm and suicide risk?

Updated: 2026-08-24T18:41:28.454597+00:00

## What matters in practice
- Establish BPD with a structured longitudinal assessment rather than diagnosing from a single crisis presentation; SCID-5-PD supports categorical or dimensional assessment of DSM-5 personality disorders. [11]
- Affective instability, abandonment fears, unstable relationships, identity disturbance, impulsivity, and chronic emptiness provide useful diagnostic discrimination; a six-criterion composite showed sensitivity of 0.99 and specificity of 0.90 in one clinical study. [8]
- Treat suicidality and self-harm as urgent targets while recognizing that chronic risk requires a sustained outpatient treatment framework; up to 10% of patients with BPD die by suicide. [21]
- Refer to a coherent BPD-specific psychotherapy, particularly DBT or psychodynamic approaches; randomized-trial meta-analysis found significant, though modest, improvement in BPD symptoms, self-harm, and suicide-related outcomes versus control interventions. [1]
- Do not start or escalate psychotropics solely because a patient presents in crisis; no specific medication or medication combination has evidence for crisis management in BPD. [20]

## Triage imminent harm before attributing symptoms to BPD

Separate acute danger from chronic baseline risk, then preserve continuity with structured outpatient care.

At every acute presentation involving suicidal ideation, suicide attempt, or self-injury, determine the immediate medical and psychiatric disposition before addressing personality formulation. Obtain a behavior-specific account of the current episode: suicidal intent, actions taken, medical lethality, timing, access to means, precipitating events, intoxication, and whether the behavior was intended to die or to regulate affect. The Suicide Attempt Self-Injury Interview is a semistructured instrument that captures topography, intent, medical severity, social context, precipitants, and outcomes of suicidal behavior and nonsuicidal self-injury. [17]

Do not downgrade acute risk because suicidality is recurrent or described as chronic. BPD is associated with substantial suicidal behavior and self-harm, and up to 10% of affected patients die by suicide. [21] Conversely, recurrent crises should not automatically trigger prolonged, unstructured admission: available literature notes concern that lengthy hospitalization without a clear treatment structure can worsen functioning, while evidence for hospitalization as suicide prevention in BPD is lacking. [13][21]

When acute containment is required, define the immediate target and the transition plan at admission: medical stabilization after self-poisoning or injury, management of intoxication or withdrawal, protection during imminent suicidal intent, or treatment of a severe comorbid episode. Before discharge, reconnect the patient to a named outpatient clinician or structured program and specify how recurrent self-harm, suicidal urges, and missed appointments will be handled. Crisis interventions are frequently needed in BPD, but the evidence base for crisis-specific interventions remains limited. [15][19]
- Document suicidal behavior and nonsuicidal self-injury separately; purpose, intent, medical severity, and context alter the immediate intervention and longitudinal treatment target. [17][24]
- Treat self-harm as a behavior requiring direct follow-up even when suicidal intent is denied; DBT specifically targets nonsuicidal self-injury, suicide-related behaviors, therapy-interfering behaviors, and quality-of-life-interfering behaviors. [24]
- Avoid using hospitalization alone as the longitudinal suicide-prevention strategy; pair any acute level-of-care intervention with an organized outpatient treatment plan. [21][13]

*Crisis decisions should follow the current behavior, intent, and need for medical or psychiatric containment rather than the BPD label alone. [17][21]*

| Presentation pattern | Immediate decision focus | Next management step |
| --- | --- | --- |
| Suicide attempt or self-injury with uncertain intent | Clarify intent, medical severity, precipitants, concurrent events, and outcomes with a structured behavior-focused assessment. [17] | Address medical consequences and determine whether imminent psychiatric containment is needed; arrange structured follow-up for both suicide-related behavior and self-injury. [17][24] |
| Recurrent suicidal ideation or self-harm crisis | Do not equate recurrence with absence of danger; BPD carries a meaningful suicide mortality risk. [21] | Use a defined crisis response linked to longitudinal psychotherapy rather than relying on prolonged unstructured hospitalization. [13][21] |
| Crisis presentation prompting medication request | Identify a separately diagnosable target condition or symptom target before prescribing. [4] | Do not initiate a drug or drug combination solely as crisis treatment for BPD. [20] |

## Confirm a pervasive personality pattern with structured assessment

The diagnostic task is to establish enduring cross-context dysfunction and identify competing episodic syndromes.

Use a longitudinal history across relationships, work or school, self-concept, impulsive behavior, affect regulation, and prior treatment rather than assigning BPD from a single emergency encounter. A semistructured assessment such as the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD) evaluates all 10 DSM-5 personality disorders and can support categorical or dimensional diagnosis. The associated SCID-5 Screening Personality Questionnaire is a brief self-report screen intended to reduce the time required for the full interview; a positive screen should lead to interview-based diagnostic assessment, not stand alone as the diagnosis. [11]

Prioritize the criterion pattern with the strongest observed discrimination in clinical samples. Affective instability had the greatest individual discriminatory performance in one study, with an area under the receiver operating characteristic curve of 0.84. Abandonment fears, unstable relationships, identity disturbance, impulsivity, and chronic emptiness each had area under the curve values of 0.75 to 0.79; combining these six features produced an area under the curve of 0.98, sensitivity of 0.99, and specificity of 0.90 in that dataset. [8]

The principal diagnostic fork is pervasive BPD pathology versus an episodic mood, psychotic-spectrum, substance-related, or trauma-related presentation that can mimic affective instability, impulsivity, dissociation, or interpersonal disruption. Specifically assess whether mood change, psychotic symptoms, or behavioral dyscontrol is confined to discrete episodes versus embedded in enduring identity and relationship dysfunction. Diagnostic work should also identify co-occurring mental disorders and substance-use conditions because they may require independent treatment and alter the acute risk formulation. [8][4][23]
- Use collateral records and prior treatment history when possible to establish persistence and cross-situational impairment; a single self-report measure should not substitute for diagnostic interviewing. [11]
- Ask directly about recurrent suicidal behavior, self-harm, impulsive acts, dissociation, intense anger, identity disturbance, abandonment sensitivity, and relationship instability because these domains determine treatment targets and crisis planning. [14][24]
- Do not replace BPD assessment with a trauma-only formulation when the longitudinal personality pattern is present; accurate diagnosis directs patients toward targeted psychotherapy. [7]

*Structured assessment tools and high-yield clinical domains for BPD diagnosis. [8][11]*

| Assessment element | Interpretation | Action |
| --- | --- | --- |
| SCID-5-PD | Semistructured interview for DSM-5 personality disorders; permits categorical or dimensional assessment. [11] | Use to confirm BPD and assess other personality disorders when diagnostic uncertainty or treatment planning warrants formal assessment. [11] |
| SCID-5-SPQ | Brief self-report screening instrument designed to reduce time required for the full SCID-5-PD assessment. [11] | Use as a screen; follow positive or clinically discordant results with diagnostic interview. [11] |
| Affective instability | Most discriminating individual BPD criterion in one clinical study, AUC 0.84. [8] | Assess temporal pattern and relation to interpersonal stressors; evaluate for episodic mood syndromes when symptoms are sustained or syndromic. [8] |
| Six-feature cluster | Abandonment fears, unstable relationships, identity disturbance, impulsivity, chronic emptiness, and affective instability had high composite discrimination in one study. [8] | Use as a focused diagnostic interview framework, while retaining full personality-disorder and comorbidity assessment. [8][11] |

## Refer to a coherent BPD-specific psychotherapy

Psychotherapy is the core treatment; select a model that can directly address the patient’s dominant behavioral targets.

Make referral to a structured psychotherapy the central treatment decision after diagnostic confirmation. A meta-analysis of 27 psychotherapy trials found that psychotherapies for BPD, particularly DBT and psychodynamic approaches, significantly improved BPD-relevant outcomes including symptoms, self-harm or parasuicidal behavior, and suicide-related outcomes compared with control interventions; the overall benefits were modest. [1] This supports treatment referral even when medication requests dominate the initial visit.

Select DBT when recurrent suicidal behavior, nonsuicidal self-injury, therapy-interfering behavior, or severe emotion-driven behavioral dyscontrol is the leading clinical target. DBT uses a behavioral hierarchy that prioritizes life-threatening behaviors, then treatment-interfering behaviors, then behaviors interfering with quality of life; skills acquisition aims to improve emotional and behavioral control. [24] The treatment frame is therefore particularly useful when the patient’s repeated emergency use or self-harm has become the immediate barrier to outpatient progress.

Where DBT is unavailable or not acceptable, refer to another coherent BPD-focused model rather than offering unsupported eclectic crisis care. Mentalization-based treatment, transference-focused psychotherapy, and good psychiatric management are established BPD-focused approaches, and psychodynamic treatments have supportive trial-level meta-analytic evidence. [1][24][7] The practical selection criterion is not a presumed universal superiority of one model, but whether the program can maintain continuity, address the patient’s primary targets, and coordinate crisis care.
- At referral, state the highest-priority target explicitly: suicidal behavior, nonsuicidal self-injury, missed treatment, substance-related impulsivity, or relationship-driven destabilization. DBT’s target hierarchy is designed for this sequencing. [24]
- Maintain one coordinating prescriber or psychiatric clinician when pharmacotherapy, psychotherapy, primary care, substance-use treatment, and social services are involved; guidelines describe outpatient psychiatric care as the locus for diagnosis, treatment, and integration across services. [5]
- Prefer outpatient or day-hospital organization when clinically safe; guidance emphasizes organizing BPD treatment as far as possible in outpatient care and, when hospitalization is used, in day-hospital conditions. [5]

*Psychotherapy selection by dominant treatment target. [1][24][7]*

| Clinical priority | Treatment implication | Evidence-supported option |
| --- | --- | --- |
| Recurrent suicide attempts or nonsuicidal self-injury | Use a treatment with explicit behavioral targets and skills-based management of emotional and behavioral dyscontrol. [24] | Dialectical behavior therapy. [1][24] |
| Broad BPD symptoms with interpersonal and identity dysfunction | Refer to a coherent BPD-specific model rather than treatment as usual alone. [1][7] | DBT, psychodynamic approaches, mentalization-based treatment, transference-focused psychotherapy, or good psychiatric management. [1][24][7] |
| Fragmented care across emergency, addiction, social, and outpatient settings | Assign a coordinating outpatient treatment team and integrate services around a shared plan. [5] | Organized outpatient psychiatric treatment with psychotherapy and coordinated ancillary services. [5] |

## Use medications for defined comorbid targets, not for BPD itself

Medication can be adjunctive, but crisis prescribing and polypharmacy can displace definitive care.

Do not prescribe a psychotropic medication as a primary treatment for the BPD syndrome or as a reflex response to acute distress. A Cochrane review evaluates pharmacologic interventions for BPD, and clinical guidance states that medication is commonly started during crisis despite no evidence for any specific drug or drug combination in crisis management. [12][20] Earlier review literature similarly concluded that there was no evidence for BPD-specific pharmacotherapy. [18]

Before prescribing, define the independent syndrome or symptom target, the measurable outcome, and the planned duration. Guidance for patients with addiction and personality disorder recommends psychotherapy whenever possible, complemented by symptom-targeted pharmacotherapy. [4] In practice, this means treating a separately established depressive disorder, bipolar-spectrum disorder, psychotic disorder, substance-use disorder, or other comorbidity according to its own treatment pathway while continuing BPD-focused psychotherapy.

Avoid serial medication additions after each interpersonal or self-harm crisis. Crisis prescribing can create a momentum toward further prescribing without evidence of benefit for the crisis itself. [20] Reassess whether a medication is treating a documented comorbidity, causing adverse effects that worsen impulsivity or adherence, or serving as a substitute for access to structured psychotherapy.
- Do not represent antipsychotics, antidepressants, anticonvulsants, or medication combinations as established BPD-specific treatments. [12][18]
- For each ongoing psychotropic, document the target diagnosis, target symptom, benefit, adverse effects, and whether continuation remains justified alongside psychotherapy. [4][20]
- When substance use is present, coordinate addiction treatment with the BPD treatment plan rather than treating recurrent intoxication-related crises as personality symptoms alone. [4][5]

*Medication decisions in BPD should be tied to a specific target rather than to crisis intensity. [4][12][20]*

| Clinical situation | Medication decision | Rationale |
| --- | --- | --- |
| Acute BPD crisis without a separate drug-responsive syndrome | Do not start a medication or medication combination solely for crisis management. [20] | No specific drug or combination has evidence for crisis management in BPD. [20] |
| Documented co-occurring psychiatric disorder | Use symptom-targeted pharmacotherapy as an adjunct to psychotherapy. [4] | Pharmacotherapy is positioned as complementary to psychotherapy when a specific symptom target or comorbidity is identified. [4] |
| Repeated requests for medication escalation after crises | Review indication and avoid automatic addition of agents. [20] | Crisis prescribing can lead to further prescribing despite lack of crisis-specific evidence. [20] |

## Monitor behavior, functioning, treatment engagement, and transitions of care

Follow outcomes that drive morbidity and utilization, not symptom labels alone.

Track suicidal behavior and nonsuicidal self-injury separately at each visit, including frequency, method, intent, medical severity, precipitants, and emergency utilization. The SASII framework distinguishes these clinically important dimensions and can anchor a longitudinal behavioral record. [17] Escalate the treatment response when life-threatening behaviors recur, rather than merely documenting passive ideation or repeating an unchanged medication regimen.

Measure treatment engagement as a clinical outcome. DBT identifies therapy-interfering behaviors as a direct treatment target, alongside life-threatening and quality-of-life-interfering behaviors. [24] Missed visits, repeated emergency presentations, abrupt treatment discontinuation, and inability to coordinate between clinicians should prompt review of the treatment structure and the patient’s access to an appropriate level of psychotherapy.

Coordinate care transitions actively. Guidance recommends a specialized clinical team with continuing education and close collaboration among outpatient psychiatry, hospital services, primary care, substance-use treatment, social services, and psychotherapy providers. [5] This is most important after emergency or inpatient care, when fragmented plans can reinforce recurrent crisis utilization.
- At each follow-up, record: interval suicide attempts, nonsuicidal self-injury, suicidal intent, medical treatment after self-harm, substance use around the event, emergency contacts, and psychotherapy attendance. [17][24]
- Use recurrence of life-threatening behavior or therapy-interfering behavior as a trigger to reassess treatment intensity, coordination, and fit of the psychotherapy model. [24][5]
- After any emergency or inpatient episode, communicate the behavioral formulation and outpatient plan directly to the receiving psychotherapist and prescriber. Coordinated care is a stated organizational treatment principle. [5]

*Longitudinal monitoring targets for BPD-focused care. [5][17][24]*

| Domain | What to document | Action if worsening |
| --- | --- | --- |
| Suicidal behavior and self-injury | Intent, method, medical severity, social context, precipitating and concurrent events, and outcomes. [17] | Reassess acute safety needs and revise the structured behavioral treatment plan. [17][24] |
| Therapy engagement | Attendance, dropout risk, and behaviors that interfere with treatment. [24] | Address therapy-interfering behavior within the treatment hierarchy and improve care coordination. [24][5] |
| Care fragmentation | Emergency, hospital, primary care, addiction, psychotherapy, and social-service involvement. [5] | Assign and communicate a shared outpatient treatment plan across services. [5] |

## References
1. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis — jamanetwork.com — https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2605200
2. Psychosocial dynamics of suicidality and nonsuicidal self-injury: a digital linguistic perspective | npj Mental Health Research — www.nature.com — https://www.nature.com/articles/s44184-025-00142-w
3. Screening for and Treatment of Suicide Risk Relevant to ... — www.acpjournals.org — https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-158-10-201305210-00642
4. Patients with addiction and personality disorder — journals.lww.com — https://journals.lww.com/co-psychiatry/fulltext/2007/01000/patients_with_addiction_and_personality_disorder_.14.aspx
5. Clinical Practice Guidelines for Assessment and... : Indian Journal of Psychiatry — journals.lww.com — https://journals.lww.com/indianjpsychiatry/_layouts/15/oaks.journals/downloadpdf.aspx?an=01363795-202365020-00015
6. Clinical Practice Guidelines for Assessment and ... — journals.lww.com — https://journals.lww.com/indianjpsychiatry/_layouts/15/oaks.journals/downloadpdf.aspx?an=
7. Harvard Review of Psychiatry — journals.lww.com — https://journals.lww.com/hrpjournal/pages/default.aspx
8. Diagnostic accuracy of DSM-5 borderline personality disorder criteria: Toward an optimized criteria set — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0165032720328354
9. Clinical utility of the DSM-5 alternative model for borderline personality disorder: Differential diagnostic accuracy of the BFI, SCID-II-PQ, and PID-5 — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0010440X17302079
10. Efficient screening and outcome assessment for borderline ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0010440X25000847
11. Structured Clinical Interview for DSM-IV - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/neuroscience/structured-clinical-interview-for-dsm-iv
12. Pharmacological interventions for people with borderline ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956.pub2/full
13. individuals with self-harm and acute risk of suicide. — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/47/NCT02985047/Prot_SAP_000.pdf
14. Clinical investigation plan — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/07/NCT06601907/Prot_SAP_000.pdf
15. Crisis interventions for people with borderline personality ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009353.pub2/abstract
16. Crisis interventions for adults with borderline personality ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009353.pub3/references/zh
17. Study Details | NCT07569198 | Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT) | ClinicalTrials.gov — clinicaltrials.gov — https://clinicaltrials.gov/study/NCT07569198
18. Borderline Personality Disorder in Adolescence | Pediatrics — pediatrics.aappublications.org — http://pediatrics.aappublications.org/content/early/2014/09/17/peds.2013-3677
19. Crisis interventions for adults with borderline personality disorder — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9511988
20. MANAGEMENT OF CRISES - Borderline Personality Disorder - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK55407
21. Suicidality in Borderline Personality Disorder — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6632023
22. Short‐term psychodynamic psychotherapies for common ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004687.pub4/references
23. Borderline personality disorder: a comprehensive review of ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10786009
24. Strategies to Deal With Suicide and Non-suicidal Self-Injury in Borderline Personality Disorder, the Case of DBT - PMC — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304419?term=

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.